↓ Skip to main content

Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database

Overview of attention for article published in Frontiers in Neurology, July 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database
Published in
Frontiers in Neurology, July 2020
DOI 10.3389/fneur.2020.00615
Pubmed ID
Authors

Kensuke Nakamura, Hiroyuki Ohbe, Hiroki Matsui, Yuji Takahashi, Aiki Marushima, Yoshiaki Inoue, Kiyohide Fushimi, Hideo Yasunaga

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 21%
Other 1 7%
Student > Bachelor 1 7%
Lecturer > Senior Lecturer 1 7%
Student > Master 1 7%
Other 3 21%
Unknown 4 29%
Readers by discipline Count As %
Medicine and Dentistry 7 50%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Environmental Science 1 7%
Agricultural and Biological Sciences 1 7%
Neuroscience 1 7%
Other 0 0%
Unknown 3 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2020.
All research outputs
#2,866,046
of 23,220,133 outputs
Outputs from Frontiers in Neurology
#1,766
of 12,143 outputs
Outputs of similar age
#76,286
of 398,655 outputs
Outputs of similar age from Frontiers in Neurology
#178
of 443 outputs
Altmetric has tracked 23,220,133 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,143 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,655 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 443 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.